Picture of DURECT logo

DRRX — DURECT News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Durect Corp Expected To Post A Loss Of 33 Cents A Share: Earnings Preview

* DURECT Corp  DRRX.OQ   DRRX.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 27 for the
period ending December 31 2023
    * The Cupertino California-based  company is expected to
report a
25.3% decrease in revenue to $2.477 million from $3.32 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for DURECT Corp is for a
loss
of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DURECT Corp
is
$6.75​, above​ its last closing price of $1.17. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.42       -0.42      -0.14     Beat    66.7
 Jun. 30 2023  -0.48       -0.51      -0.42     Beat    17.6
 Mar. 31 2023  -0.52       -0.53      -0.47     Beat    11.3​
 Dec. 31 2022  -0.54       -0.55      -0.46     Beat    15.9
 ​​Sep.        -0.10       -0.10      -0.10     Met     0
 30 2022                                                
 Jun. 30 2022              -0.47      -0.50     Missed  -7.1​
 Mar. 31 2022  -0.50       -0.53      -0.50     Beat    6.2
 Dec. 31 2021              -0.47      -0.30     Beat    35.7
 This summary was machine generated March 25 at 20:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on DURECT

See all news